Archives

img-01

Plans for India’s New Regulatory Agency

This fall, India has announced plans to replace its current Central Drugs Standard Control Organization (CDSCO) with a new agency, the Central Drugs Authority of India (CDAI). The government hopes that the CDAI will help centralize the product approval process and improve... Read More

img-01

Sourcing Medical Devices in Asia: An Introduction

This report helps medical device manufacturers and distributors better understand how to source from Asia. Topics covered include: how to identify manufacturers, how to perform due diligence, what to look for during factory visits, contract negotiations, regulatory requirements, logistics, quality control, and... Read More

img-01

New Clarifications for Medical Devices in India

In September 2007, India’s medical regulatory body, the Central Drugs Standard Control Organization (CDSCO), released an “Additional Clarification to Guidelines for Import Registration and Manufacture of Medical Devices”. This Clarification covers several topics, from regulating more categories of medical devices to setting... Read More

img-01

India Drafts Legislation for Medical Devices

The Central Government in India has recently drafted legislation to ensure quality control of vital life-saving medical devices such as endoscopes and pacemakers. Drafted by the Sree Chitra Tirunal Institute for Medical Sciences and Technology, the draft has been forwarded to the... Read More

img-01

New E-filing Pricing System for India

India’s National Pharmaceuticals Pricing Authority (NPPA) has recently introduced an online e-filing system for applicants wishing to apply for pricing or revised pricing of their medical product. The price list is listed under Forms III, IV, and V of the Drug Price... Read More

img-01

Medical Device Market Opportunities in India

For a long time, India was closed to many foreign markets through government protectionism and a nationalistic tariff system. Today, however, India is ripe for market entry for many industries, including medical devices. Entering soon (or expanding one's business there) will help... Read More

img-01

New Regulations for Drug Pricing in India

India’s National Pharmaceutical Pricing Authority (NPPA) has issued new regulations on drugs not currently under the mandatory price control list. These drugs are referred to as “non-scheduled formulations” and are currently sold freely. Companies will be short-listed for price control if they... Read More